206 related articles for article (PubMed ID: 20696823)
21. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
22. Disruption of Francisella tularensis Schu S4 iglI, iglJ, and pdpC genes results in attenuation for growth in human macrophages and in vivo virulence in mice and reveals a unique phenotype for pdpC.
Long ME; Lindemann SR; Rasmussen JA; Jones BD; Allen LA
Infect Immun; 2013 Mar; 81(3):850-61. PubMed ID: 23275090
[TBL] [Abstract][Full Text] [Related]
23. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
[TBL] [Abstract][Full Text] [Related]
24. Zinc Acquisition Mechanisms Differ between Environmental and Virulent Francisella Species.
Moreau GB; Qin A; Mann BJ
J Bacteriol; 2018 Feb; 200(4):. PubMed ID: 29109188
[TBL] [Abstract][Full Text] [Related]
25. Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis.
Horzempa J; Carlson PE; O'Dee DM; Shanks RM; Nau GJ
BMC Microbiol; 2008 Oct; 8():172. PubMed ID: 18842136
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the siderophore of Francisella tularensis and role of fslA in siderophore production.
Sullivan JT; Jeffery EF; Shannon JD; Ramakrishnan G
J Bacteriol; 2006 Jun; 188(11):3785-95. PubMed ID: 16707671
[TBL] [Abstract][Full Text] [Related]
27. Identification of mechanisms for attenuation of the FSC043 mutant of Francisella tularensis SCHU S4.
Lindgren M; Tancred L; Golovliov I; Conlan W; Twine SM; Sjöstedt A
Infect Immun; 2014 Sep; 82(9):3622-35. PubMed ID: 24935978
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
Santiago AE; Mann BJ; Qin A; Cunningham AL; Cole LE; Grassel C; Vogel SN; Levine MM; Barry EM
Pathog Dis; 2015 Aug; 73(6):ftv036. PubMed ID: 25986219
[TBL] [Abstract][Full Text] [Related]
29. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
[No Abstract] [Full Text] [Related]
30. A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence.
Forestal CA; Gil H; Monfett M; Noah CE; Platz GJ; Thanassi DG; Benach JL; Furie MB
Microb Pathog; 2008 Jun; 44(6):512-23. PubMed ID: 18304778
[TBL] [Abstract][Full Text] [Related]
31. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response.
Barrigan LM; Tuladhar S; Brunton JC; Woolard MD; Chen CJ; Saini D; Frothingham R; Sempowski GD; Kawula TH; Frelinger JA
Infect Immun; 2013 Jun; 81(6):2028-42. PubMed ID: 23529616
[TBL] [Abstract][Full Text] [Related]
32. Contribution of citrulline ureidase to Francisella tularensis strain Schu S4 pathogenesis.
Mahawar M; Kirimanjeswara GS; Metzger DW; Bakshi CS
J Bacteriol; 2009 Aug; 191(15):4798-806. PubMed ID: 19502406
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of heme utilization by Francisella tularensis.
Lindgren H; Lindgren L; Golovliov I; Sjöstedt A
PLoS One; 2015; 10(3):e0119143. PubMed ID: 25756756
[TBL] [Abstract][Full Text] [Related]
34. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
[TBL] [Abstract][Full Text] [Related]
35. A Francisella tularensis SCHU S4 mutant deficient in γ-glutamyltransferase activity induces protective immunity: characterization of an attenuated vaccine candidate.
Ireland PM; LeButt H; Thomas RM; Oyston PCF
Microbiology (Reading); 2011 Nov; 157(Pt 11):3172-3179. PubMed ID: 21852349
[TBL] [Abstract][Full Text] [Related]
36. Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence.
Qin A; Scott DW; Mann BJ
Infect Immun; 2008 Jul; 76(7):3086-92. PubMed ID: 18458069
[TBL] [Abstract][Full Text] [Related]
37. Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly, host cell adherence, and virulence.
Chakraborty S; Monfett M; Maier TM; Benach JL; Frank DW; Thanassi DG
Infect Immun; 2008 Jul; 76(7):2852-61. PubMed ID: 18426883
[TBL] [Abstract][Full Text] [Related]
38. Characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agent bacterium, Francisella tularensis Schu S4 and the surrogate type B live vaccine strain (LVS).
Su S; Saldanha R; Pemberton A; Bangar H; Kawamoto SA; Aronow B; Hassett DJ; Lamkin TJ
Appl Microbiol Biotechnol; 2013 Oct; 97(20):9029-41. PubMed ID: 23852642
[TBL] [Abstract][Full Text] [Related]
39. Deletion of the Major Facilitator Superfamily Transporter
Balzano PM; Cunningham AL; Grassel C; Barry EM
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29311235
[No Abstract] [Full Text] [Related]
40. An AraC/XylS Family Transcriptional Regulator Modulates the Oxidative Stress Response of Francisella tularensis.
Marghani D; Ma Z; Centone AJ; Huang W; Malik M; Bakshi CS
J Bacteriol; 2021 Nov; 203(23):e0018521. PubMed ID: 34543107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
